Literature DB >> 31092463

Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study.

Yosuke Nakao1, Yo-Ichi Yamashita2, Kota Arima1, Tatsunori Miyata1, Rumi Itoyama1, Toshihiko Yusa1, Naoki Umezaki1, Takanobu Yamao1, Shigeki Nakagawa1, Hirohisa Okabe1, Katsunori Imai1, Akira Chikamoto1, Hideo Baba1.   

Abstract

BACKGROUND/AIM: Prognoses of patients with cancer can be predicted on the basis of preoperative nutrition- or inflammation-based scores; however, predicting the prognostic impact of undergoing surgery remains challenging. In this study, we investigated the usefulness of the perioperative C-reactive protein/albumin (CRP/Alb) ratio in patients with intrahepatic cholangiocarcinoma (ICC). PATIENTS AND METHODS: We retrospectively investigated 80 patients who had undergone curative resection of primary ICC between April 2002 and December 2017. We identified the time at which perioperative CRP/Alb ratio most influences the prognosis, and investigated the correlations among the perioperative CRP/Alb ratio, clinicopathological features and patient outcomes.
RESULTS: The only perioperative CRP/Alb ratios significantly associated with shorter overall survival (OS) was a high CRP/Alb ratio on POD14. High CRP/Alb ratio on POD 14 was significantly associated with older age, male sex, and the presence of postoperative complications. Finally, a high CRP/Alb ratio at POD 14 was an independent prognostic factor for poor OS.
CONCLUSION: CRP/Alb ratio on POD 14 may be a useful prognostic factor in patients with ICC who have undergone curative resections. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Perioperative C-reactive protein/albumin ratio; intrahepatic cholangiocarcinoma; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31092463     DOI: 10.21873/anticanres.13388

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.

Authors:  Kosuke Mima; Junji Kurashige; Nobutomo Miyanari; Atsushi Morito; Shinsei Yumoto; Takashi Matsumoto; Keisuke Kosumi; Mitsuhiro Inoue; Takao Mizumoto; Tatsuo Kubota; Hideo Baba
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

2.  The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study.

Authors:  Jovan Vujic; Katharina Marsoner; Valerie Wienerroither; Hans-Jorg Mischinger; Peter Kornprat
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

3.  The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis.

Authors:  Erhu Fang; Xiaolin Wang; Jiexiong Feng; Xiang Zhao
Journal:  Dis Markers       Date:  2020-01-07       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.